[HTML][HTML] COVID-19 vaccines and myocarditis: an overview of current evidence

A Hromić-Jahjefendić, A Sezer, AAA Aljabali… - Biomedicines, 2023 - mdpi.com
COVID-19 vaccines have been widely used to reduce the incidence and disease severity of
COVID-19. Questions have lately been raised about the possibility of an association …

[HTML][HTML] Side effects of COVID-19 vaccines in the middle eastern population

GM Murished, I Dandachi, W Aljabr - Frontiers in Immunology, 2023 - frontiersin.org
The COVID-19 pandemic has caused severe worldwide health concerns since its first
description as the SARS-COV-2 virus in December 2019. The wide dissemination of this …

[HTML][HTML] COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic

LE Markowitz, RH Hopkins Jr, KR Broder, GM Lee… - Vaccine, 2024 - Elsevier
During the COVID-19 pandemic, candidate COVID-19 vaccines were being developed for
potential use in the United States on an unprecedented, accelerated schedule. It was …

Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years

BQ Guo, HB Li, LQ Yang - Vaccine, 2023 - Elsevier
Background The incidence of myopericarditis after mRNA COVID-19 vaccination among
adolescents aged 12–17 years remains unknown. Therefore, we conducted a study to pool …

[HTML][HTML] Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

E Copland, M Patone, D Saatci, L Handunnetthi… - Nature …, 2024 - nature.com
The risk-benefit profile of COVID-19 vaccination in children remains uncertain. A self-
controlled case-series study was conducted using linked data of 5.1 million children in …

[HTML][HTML] The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from …

JY Sim, SY Kim, EK Kim - Osong Public Health and Research …, 2023 - ncbi.nlm.nih.gov
Objectives Age-specific information regarding myocarditis/pericarditis in adolescents
following mRNA-based coronavirus disease 2019 (COVID-19) vaccination in Asia remains …

[HTML][HTML] Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an …

N Le Corre, K Abarca, P Astudillo, M Potin, S López… - Vaccines, 2023 - mdpi.com
During the COVID-19 pandemic, the importance of vaccinating children against SARS-CoV-
2 was rapidly established. This study describes the safety of CoronaVac® in children and …

Adverse Events Following SARS-CoV-2 mRNA Vaccination in Adolescents: A Norwegian Nationwide Register-Based Study

V Bergstad Larsen, N Gunnes, JM Gran, H Boas… - medRxiv, 2023 - medrxiv.org
Background: Vaccination of older adolescents against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) started in the spring of 2021 and continued with younger …

[HTML][HTML] Impact of improper storage of ChAdOx1-S (AstraZeneca) vaccine on its efficacy and safety

M Mikołajczyk, RA Lewandowski, AG Goncharuk - Vaccines, 2022 - mdpi.com
Background: In May 2021, there was an incident regarding giving patients AstraZeneca
vaccines stored improperly. They were stored at room temperature (21 degrees centigrade) …

[HTML][HTML] COVID-19 vaccination in children: a public health priority

EJF Lima, RD Leite - Jornal de Pediatria, 2023 - SciELO Brasil
Objective: Covid-19 had a direct impact on children's health. The aim of this review was to
analyze epidemiological and clinical data, the consequences of the pandemic, and …